CARDIAC BIOMARKERS MARKET ANALYSIS

Cardiac Biomarkers Market, By Product Type (Myocardial Muscle Creatine Kinase, Myoglobin, Troponins, Brain Natriuretic Peptide or NT-proBNP, Ischemia-modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2024
Code : CMI4576
Pages :186
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Cardiac Biomarkers Market Regional Insights

To learn more about this report, Request sample copy

North America has dominated the global cardiac biomarkers market and is expected to continue its dominance over the forecast period. The region is expected to account for 40.2% of the market share in 2024. This can be attributed to the high prevalence of cardiovascular diseases in the U.S. and Canada coupled with growing elderly population. In addition, well-established healthcare infrastructure and rising healthcare spending in the region are supporting the demand for advanced cardiac diagnostic tests. The presence of leading cardiac biomarkers manufacturers and availability of reimbursement are further propelling the market growth.

Asia Pacific has emerged as the fastest growing region in the global cardiac biomarkers industry. Rapid economic development, growing medical tourism industry, and rising chronic disease burden are the key factors fueling the market in Asia Pacific countries. Countries like China and India represent huge market potential with their large geriatric population and unmet medical needs. Additionally, increasing awareness about cardiac condition diagnosis and management is boosting the adoption of cardiac biomarkers. Leading global manufacturers are shifting their focus towards the Asia Pacific region in view of opportunities for business expansion. This has enhanced the accessibility to advanced testing technologies in the region.